跳至主要内容
临床试验/NCT06289335
NCT06289335已完成2 期

Dexmedetomidine Compared With Ondansetron in Treating Postanesthetic Shivering in Patients After Regional Anesthesia for Cesarean Section-a Randomized Clinical Trial.

Hospital Central "Dr. Ignacio Morones Prieto"1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年8月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Period of time

研究概览

简要总结

Evaluate the efficiency of management with intravenous dexmedetomidine compared to intravenous ondansetron to achieve the disappearance of post-anesthetic shivering in a shorter time in the obstetric patient undergoing cesarean section under regional anesthesia.

详细描述

Randomized clinical trial with 40 pregnant patients, between 18 and 45 years old with ASA (American Society of Anesthesiologist) II or III, undergoing scheduled or emergency cesarean section with regional anesthesia and who presented grade tremor 1 based on the BSAS (Bedside shivering assessment scale) scale, at the Hospital Central from San Luis Potosi, Mexico. The main objective of this study was to quantify the time that elapsed from the end of the administration of the medication until the disappearance of the tremor, which was measured in minutes; The evaluation of the disappearance, persistence or reappearance of the tremor was solely visual by the anesthesiology staff.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ASA II or III, undergoing scheduled or emergency cesarean section with regional anesthesia (hyperbaric bupivacaine 0.5% with morphine at 1 mcg Kg-1) and who presented tremor grade >1 based on the BSAS scale

排除标准

  • Hemodynamic instability, heart disease or sinus bradycardia, allergy to any of the medications applied, psychiatric diseases or hypothermia <35.2 ºC measured by tympanic temperature.

研究组 & 干预措施

Dexmedetomidine

Active Comparator

0.3 mcg Kg-1 (actual weight) of dexmedetomidine IV in 20 mL of saline

干预措施: saline solution (Drug)

Ondansetron

Sham Comparator

8 mg ondansetron IV in 20 mL saline

干预措施: saline solution (Drug)

结局指标

主要结局

Period of time

时间窗: one hour

period of time in which post-anesthetic tremor is controlled from the moment of administration

次要结局

  • Adverse effects(one hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

MARIO AURELIO MARTÍNEZ-JIMÉNEZ

Doctor

Hospital Central "Dr. Ignacio Morones Prieto"

研究点 (1)

Loading locations...

相似试验